首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors
【2h】

Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors

机译:新型8-取代喹啉-2-羧酰胺类碳酸酐酶抑制剂的合成及生物学评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A series of novel 8-substituted-N-(4-sulfamoylphenyl)quinoline-2-carboxamides was synthesised by the reaction of 8-hydroxy-N-(4-sulfamoylphenyl) quinoline-2-carboxamide with alkyl and benzyl halides. The compounds were assayed for carbonic anhydrase (CA) inhibitory activity against four hCA isoforms, hCA I, hCA II, hCA IV, and hCA IX. Barring hCA IX, all the isoforms were inhibited from low to high nanomolar range. hCA I was inhibited in the range of 61.9–8126 nM, with compound >5h having an inhibition constant of KI = 61.9 nM. hCA II was inhibited in the range of 33.0–8759 nM, with compound >5h having an inhibition constant of 33.0 nM and compounds >5a and >5b having inhibition constants of 88.4 and 85.7 nM, respectively. hCA IV was inhibited in the range of 657.2–6757 nM. Hence, compound >5h, possessing low nanomolar hCA I and II inhibition, can be selected as a lead for the design of novel CA I and II inhibitors.
机译:通过使8-羟基-N-(4-氨磺酰基苯基)喹啉-2-羧酰胺与烷基和苄基卤化物反应,合成了一系列新型的8-取代-N-(4-氨磺酰基苯基)喹啉-2-羧酰胺。测定了化合物对四种hCA同种型hCA I,hCA II,hCA IV和hCA IX的碳酸酐酶(CA)抑制活性。除非hCA IX,所有同工型都被抑制了从低到高的纳摩尔范围。 hCA I在61.9–8126 nM范围内被抑制,化合物> 5h 的抑制常数为KI = 61.9 nM。 hCA II被抑制在33.0-8759 nM范围内,化合物> 5h 具有抑制常数33.0 nM,化合物> 5a 和> 5b 具有抑制常数分别为88.4和85.7 nM。 hCA IV被抑制在657.2-6757 nM范围内。因此,可以选择具有低纳摩尔hCA I和II抑制作用的化合物> 5h 作为设计新型CA I和II抑制剂的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号